Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Henry M. Jackson Foundation
Deal Size : $1.9 million
Deal Type : Funding
SwRI Awarded $1.9 Million Contract to Develop Treatment for COVID-19 in Collaboration with DOD
Details : Under this program, SwRI will identify drug candidates that will be tested at USAMRIID, WRAIR and TBRI with the goal of demonstrating efficacy as early as next year.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 28, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Henry M. Jackson Foundation
Deal Size : $1.9 million
Deal Type : Funding